Cargando…
New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
X-linked hypophosphataemia (XLH) is due to mutations in phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and represents the most common heritable form of rickets. In this condition, the hormone fibroblast growth factor 23 (FGF23) is produced in excessive amounts...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083817/ https://www.ncbi.nlm.nih.gov/pubmed/31965544 http://dx.doi.org/10.1007/s40272-020-00381-8 |